跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
DBL BLEOMYCIN SULFATE FOR INJECTION 15000 IU/VIAL
Approved
THERAPEUTIC
DBL BLEOMYCIN SULFATE FOR INJECTION 15000 IU/VIAL
ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED (ZHOPL) (INDIA)
🇸🇬 Health Sciences Authority
Approval Date
Oct 26, 1995
Approval ID
b13efc6848cefa26
Company
ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED (ZHOPL) (INDIA)
Type
Therapeutic
Approval Details
Approval Id
b13efc6848cefa26
Drug Name
DBL BLEOMYCIN SULFATE FOR INJECTION 15000 IU/VIAL
Product Name
DBL BLEOMYCIN SULFATE FOR INJECTION 15000 IU/VIAL
Approval Number
SIN08426P
Approval Date
1995-10-26
Registrant
PFIZER PRIVATE LIMITED
Licence Holder
PFIZER PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route Of Administration
INTRAVENOUS, SUBCUTANEOUS, INTRAMUSCULAR
Atc Code
L01DC01
Atc Item Name
bleomycin
Pharma Manufacturer Name
PFIZER PRIVATE LIMITED
Company Detail Path
/organization/pfizer-private-limited
Active Ingredients
BLEOMYCIN SULPHATE EQV BLEOMYCIN
15000 iu/vial
BLEOMYCIN SULPHATE EQV BLEOMYCIN
15,000 INTERNATIONAL UNITS/VIAL
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Oct 26, 1995
Approval ID
b13efc6848cefa26
Type
Therapeutic
Back to HSA Approvals
DBL BLEOMYCIN SULFATE FOR INJECTION 15000 IU/VIAL - HSA Drug Approval Details
